Mode
Text Size
Log in / Sign up
N/A N=72 Randomized Treatment

Ocular Comfort and the "Aging" Lens (ERBIUM)

Refractive Error

Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Aug 2012
Primary outcome: Primary: Phase 3: Ocular Comfort, Lens Age 1 Day, Hour 1 — 76; 88 Units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Habitual contact lens (Device); Lotrafilcon B contact lens (Device); Contact lens cleaning and disinfecting system (ClearCare) (Device)
Age
Pediatric, Adult, Older Adult · 17+ yrs
Sex
All
Sponsor
CIBA VISION
Primary completion
Jul 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Phase 3: Ocular Comfort, Lens Age 1 Day, Hour 1
76; 88
PRIMARY
Phase 3: Ocular Comfort, Lens Age 1 Day, Hour 10
69; 76
PRIMARY
Phase 3: Ocular Comfort, Lens Age 1 Day, End of Day
65; 67
PRIMARY
Phase 3: Ocular Comfort, Lens Age 14 Days, Hour 1
80; 79
PRIMARY
Phase 3: Ocular Comfort, Lens Age 14 Days, Hour 10
77; 64
PRIMARY
Phase 3: Ocular Comfort, Lens Age 14 Days, End of Day
72; 60
PRIMARY
Phase 3: Ocular Comfort, Lens Age 27 Days, Hour 1
78; 74
PRIMARY
Phase 3: Ocular Comfort, Lens Age 27 Days, Hour 10
72; 63
PRIMARY
Phase 3: Ocular Comfort, Lens Age 27 Days, End of Day
66; 57

Summary

The purpose of this trial was to evaluate the factors affecting comfortable contact lens wear and how those factors affect contact lens replacement frequency.

Eligibility Criteria

Inclusion Criteria

  • At least 17 years of age.
  • Ocular exam in the last two years.
  • Currently wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis with a monthly replacement schedule.
  • Wearing contact lenses at least five days per week for a minimum of 10 hours each day.
  • Able to wear lenses in the available power range with a best-corrected visual acuity of at least 20/32 in both eyes.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Any ocular disease.
  • Systemic condition that may affect a study outcome.
  • Using any systemic or topical medications that may affect ocular health.
  • Wears lenses on an extended or continuous wear schedule.
  • Habitually wears multifocal lenses.
  • Other protocol-defined exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01198600). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search